RNA Analytical Quality/Resources
-
Oligonucleotides: Where We Are And Where We Would Like To Go
9/8/2024
This presentation provides an overview of oligonucleotide bioanalysis's current status and future directions. We will look into the advantages and disadvantages of various bioanalytical techniques.
-
High-Sensitivity IVT mRNA Analysis
2/20/2025
Quality analysis of in vitro transcribed (IVT) has become an essential part of biotherapeutic workflows. Discover a high-sensitivity kit made for analyzing IVT mRNA quality to advance your research.
-
Probing RNA Base Pairing And Ligand Interactions In Solution With Infrared-Based MMS
2/21/2025
Discover why Microfluidic Modulation Spectroscopy (MMS) is a novel, label-free, solution-based infrared technique for probing RNA base pairing and ligand interactions.
-
Assessing Doggybone DNA For In Vitro Transcription
4/26/2024
In this study, we evaluated the performance of two dbDNA IVT templates, each encoding the same mRNA (firefly luciferase or Fluc), by looking at the mRNA purity and in vivo potency of the mRNA IVT’d from each template.
-
Optimizing qPCR For Broad-Range Transcript Detection In Anti-PD-1 Therapy
4/23/2025
Optimize qPCR protocols for greater sensitivity and reproducibility to accurately measure immune-related gene expression and better identify patients who will benefit from anti-PD-1 immunotherapy.
-
Methods for mRNA Poly(A) Sizing
4/26/2024
This study used Oxford Nanopore Technologies' Direct RNA Sequencing Kit and obtained successful sizing of poly(A) tail regions. The results are presented in a histogram and table format.
-
Exploring The Spatial Distribution Of mRNA-Lipid Nanoparticles Using MALDI MSI
4/23/2025
Learn how leveraging high-resolution MALDI-MSI can advance the development of lipid nanoparticle-based therapies, uncovering spatial biodistribution, pharmacokinetics, and organ-specific variability.
-
Top 8 Benefits Of Mass Spectrometry Imaging Early In Drug Development
9/1/2024
Here we explore the top 8 benefits of using mass spectrometry imaging in the oncology drug discovery and early development stages.
-
Size Matters: Mastering Size Exclusion For Oligos
12/15/2025
Learn how to separate molecules strictly by size, effectively remove salts, and select the correct pore specifications for a gentle, non-destructive purification workflow.
-
Extending The Lower Limits Of Quantification Of A Therapeutic Oligonucleotide Through Microflow LC-MS/MS
3/4/2022
Here a solution is presented to widely recognized challenges with ionpairing reversed phase liquid chromatography (IP-RP LC) through a novel microflow LC-MS strategy.